15-57262116-C-CT
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_207037.2(TCF12):c.1491dupT(p.Val498CysfsTer12) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_207037.2 frameshift
Scores
Clinical Significance
Conservation
Publications
- TCF12-related craniosynostosisInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia, ClinGen
- hypogonadotropic hypogonadism 26 with or without anosmiaInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- Kallmann syndromeInheritance: AD, AR Classification: STRONG Submitted by: Franklin by Genoox
- isolated brachycephalyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- isolated plagiocephalyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_207037.2. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TCF12 | NM_207037.2 | MANE Select | c.1491dupT | p.Val498CysfsTer12 | frameshift | Exon 17 of 21 | NP_996920.1 | ||
| TCF12 | NM_001322151.2 | c.1491dupT | p.Val498CysfsTer12 | frameshift | Exon 17 of 21 | NP_001309080.1 | |||
| TCF12 | NM_001322159.3 | c.1491dupT | p.Val498CysfsTer12 | frameshift | Exon 17 of 21 | NP_001309088.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TCF12 | ENST00000333725.10 | TSL:1 MANE Select | c.1491dupT | p.Val498CysfsTer12 | frameshift | Exon 17 of 21 | ENSP00000331057.6 | ||
| TCF12 | ENST00000267811.9 | TSL:1 | c.1419dupT | p.Val474CysfsTer12 | frameshift | Exon 16 of 20 | ENSP00000267811.5 | ||
| TCF12 | ENST00000557843.5 | TSL:1 | c.1419dupT | p.Val474CysfsTer12 | frameshift | Exon 16 of 20 | ENSP00000453737.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Pathogenic:3
Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 32620954, 23354436, 27102868, 28474983, 33904513, 36268624)
This sequence change creates a premature translational stop signal (p.Val498Cysfs*12) in the TCF12 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TCF12 are known to be pathogenic (PMID: 23354436, 32620954). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with Kallman syndrome and TCF12-related craniosynostosis (PMID: 32620954, 33904513). ClinVar contains an entry for this variant (Variation ID: 55912). For these reasons, this variant has been classified as Pathogenic.
HYPOGONADOTROPIC HYPOGONADISM 26 WITH ANOSMIA Pathogenic:1
TCF12-related craniosynostosis Pathogenic:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at